ABSTRACT. Background: For infusion therapy, polyvinylchloride (PVC)-infusion lines are commonly used. In this study, we examined the temperature dependency and the dynamics of extraction in the time course of infusion. Methods: PVC-infusion lines used on the newborn ICU were perfused with a typical 24-hour fat infusion. We collected the perfused solution and measured the concentration of DEHP. This procedure was carried out at 27°C and 33°C. In another experiment, we examined the extraction rate in the time course of a 24-hour infusion. The infusion was collected every 4 hours. Results: We discovered that extraction of DEHP depends highly on the surrounding temperature. Whereas at 27°C, the extraction of DEHP was 422.78 g/mL, the leaching reached 540.78 g/mL at 33°C under otherwise identical conditions. This is important because the temperature on a newborn ICU is between 31 and 37°C in an incubator. In the other experiment, we found out that the extraction rate rose from 25.44 g/mL in the first 4 hours to 478.1 g/mL after 24 hours. Conclusions: The result of this study is that the actual daily load of DEHP for a 2-kg newborn is 30% higher than measured before. The rate of extraction is dependent on the time of contact between solution and tubing. If PVC-infusion systems are used, solutions should be as cold as possible, and infusion time should be as short as possible. It is well known that medical devices made from polyvinylchloride (PVC) leach diethyl-hexylphthalate (DEHP), a plasticizer commonly used to keep the material flexible. The extraction from hemodialysis systems, blood bags, parenteral nutrition containers, PVC food containers, and wrappings has been examined intensively for several years.
It is well known that medical devices made from polyvinylchloride (PVC) leach diethyl-hexylphthalate (DEHP), a plasticizer commonly used to keep the material flexible. The extraction from hemodialysis systems, blood bags, parenteral nutrition containers, PVC food containers, and wrappings has been examined intensively for several years. [1] [2] [3] [4] [5] [6] [7] [8] [9] Because our group was looking for candidate substances responsible for the hepatobiliary dysfunction under total parenteral nutrition (TPN), we wondered whether plasticizers from TPN-infusion systems would leach in considerable doses.
Astonishingly, we detected a high extraction from PVC lines, which exposes newborns to doses of Ͼ5 mg/kg! 10, 11 These doses had never been seen before and are 5 times higher than those in hemodialysis systems. [2] [3] [4] Furthermore, these doses affect delicate and critically ill newborns with immature organ systems.
Because our experiments were carried out at 27°C and temperature in the intensive care unit (ICU) is 31°C and up to 37°C in the incubator, we examined the dependency of extraction on temperature. To clarify the dynamics of extraction, we analyzed the extraction in 4-hour fractions during 24 hours of infusion.
CLINICAL RELEVANCY
The amount of DEHP extracted from PVC-infusion lines is in clinically relevant doses. The DEHP load on a vulnerable immature newborn in the ICU is 30% higher than expected from our earlier experiments. More research is needed to evaluate clinical effects of these high doses. It is known that DEHP modulates xenobiotic-metabolizing enzymes of the liver. This could probably be one cause for several illnesses in newborns that we haven't explained until now, such as the hepatobiliary dysfunction after long-term parenteral nutrition. Syringes (polyethylene) for the use in infusion pumps were prepared with the typical composition for 24-hour fat infusion in 2-kg neonates: 25 mL lipid emulsion 20% (Intralipid; Fresenius Co, Bad Homburg, Germany), 2 mL of a solution containing thiaminnitrate, riboflavine, nicotinamid, pyridoxine, natriumpanthothenate, biotin, folic acid, and cyanocobalamine (Soluvit N, Baxter, Unterschleißheim, Germany), and 2 mL of a solution containing vitamins A, D, E, and K (Vitalipid infant; Baxter, Unterschleißheim, Germany). We used fat infusion, because we know that lipophilic substances extract more DEHP from PVC lines than hydrophilic substances. Five milliliters were immediately taken for analysis. The syringes were connected to typical PVC-infusion lines prolonged by short pieces of PVC lines, which are usually used for accommodation. The total length of the tubes was 2.25 m; this is in accordance with the IV lines used on the newborn ICU. The remaining 24 mL were perfused for 24 hours through the lines and collected. All samples were taken and transported in hexane-rinsed glass bottles. This procedure was carried out at 27°C and at 33°C.
MATERIALS AND METHODS

Standard
For determination of the dynamics of extraction, we prepared the same emulsion in an identical way. Perfusion was started, and the eluate was collected every 4 hours in hexane-rinsed glass bottles. This experiment was carried out at 27°C.
Sample clean-up for the lipid emulsion was as follows: 2 mL of the emulsion was mixed with 10 mL of water and 2 g NaCl and shaken for total dissolution of the NaCl. After adding the internal standard polychloridebiphenyle (PCB) No 124 (Dr Ehrensdorfer, Angsburg, Germany), the organic phase was extracted 3 times by 10 mL dichlormethane and dried above sodium sulfate anhydrous for 1 hour. The solution was decanted, and the solvent was reduced in a rotavapor to approximately 1.5 mL. For further clean-up, a column liquid chromatographic technique based on a silica column was used. The sample was transferred to the top of the prepacked column containing glass wool and 0.7 g silica deactivated with 10% water. The column was eluted with 30 mL n-hexane-dichlormethane (vol/vol 80:20). The solvent was reduced in a rotavapor to approximately 1.5 mL, and afterwards in a smooth nitrogen stream, to a volume of 100 L. This extract was used for gas chromatographic/mass spectrometric (GC/MS) analysis of the phthalic acid, bis 2-ethylhexyl ester.
RESULTS
For both temperatures, 10 perfusions were carried out with determination of the DEHP load before and after perfusion of the tubing system. The results show reliable values.
The extraction at 27°C was found to be as high as 422.78 Ϯ 47.39 g/mL (range, 329.15 to 490.40 g/mL; Table I ). At 33°C, extraction reached 540.78 Ϯ 32.61 g/mL (range, 487.8 -592.4 g/mL; Table II ). The 6°i ncrease in temperature between 27°C and 33°C resulted in an increase in extraction of 118 g/mL, which is almost 30% (Fig. 1) . Consequently, the dose for a 2-kg newborn in the ICU reaches 13 mg, or 6.5 mg/kg body weight.
In 10 experiments, the perfused lipid emulsions were collected in 4-hour intervals; each probe contained 4 mL (Table III) . The amount of DEHP extracted was low in the first 4 hours (25.44 Ϯ 3.098 g/mL) but then rapidly rose to extraction rates of 478.06 Ϯ 16.27 g/mL between 20 and 24 hours (Fig. 2) . 
DISCUSSION
Recently we detected that the extraction of DEHP from commonly used PVC-infusion systems by various infusions is alarmingly high. 10 In this investigation we showed that there is a steep temperature gradient for the DEHP extraction within the range of temperatures that neonatal ICUs use. Our earlier experiments were all carried out at 27°C. The temperature in ICUs is higher and usually around 30°C, and the temperature within an incubator can reach 37°C. The extraction by 24-mL lipid infusions at 33°C in 24 hours was determined to be 13 mg instead of 10 mg at 27°C, and there is every reason to believe that the temperature gradient is similar with other infusions. One must add 20% to 30% to the doses found in our earlier experiments for a correct estimation of the load of DEHP that the infants are exposed to. Thus, the effective dose of DEHP for a typical 2-kg newborn through the nutrition solution itself (amino acid/glucose/lipids) is 13 mg minimum. Depending on additional medication or administration of blood products, the amount could easily rise to Ͼ20 mg, corresponding to Ͼ10 mg/kg of body weight! There are no studies on humans with such high doses of DEHP. Studies on animals show different sorts of 
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changes such as increased activity of liver enzymes (morphologic changes in bile ducts), induction of peroxisomal enzymes and cytochrome P450 system, decreased fertility, and inhibition of spermatogenesis under this dose of DEHP. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] In the second experiment, we examined the dynamics of DEHP extraction in the course of perfusion of the tubing. The extraction rate seems to be directly correlated to the time of contact between emulsion and tubing within the first 12 hours. From 16 to 20 hours and 20 to 24 hours, the graph seems to plateau. To date, we do not have an explanation for this observation, but obviously the mechanism of extraction is complex. What is clear from the presented results is that irrigation of the tubing or rejection of the first portion is of no use to prevent contamination of the infusions with DEHP.
Although the direct toxicity of DEHP is low, the substance and its metabolite mono-ethylhexyl-phthalate (MEHP) are known to interfere with multiple enzyme systems in various organs. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Its effect on xenobiotic metabolizing enzymes and oxidative stress 13 These phase II enzymes make xenobiotics more water soluble for excretion. An inhibition might be followed by forced toxicity of xenobiotics. Second, DEHP influences cytochromes and other oxidases. 14 These phase I enzymes are responsible for metabolization of xenobiotics, which can make them more or less toxic. Inhibition or stimulation by DEHP could have different effects on metabolism of xenobiotics and thus on their toxicity. In both cases a toxic effect on corresponding cells, ie, liver cells, could be suspected or at least hypothesized. This topic is currently under investigation by our group.
Looking at these facts and hypotheses, the high doses of DEHP that we found in the earlier experiments and which are affirmed by the present results are of serious concern.
